Molecular Biology News and Research

RSS

Molecular biology is the study of biology at a molecular level. The field overlaps with other areas of biology and chemistry, particularly genetics and biochemistry. Molecular biology chiefly concerns itself with understanding the interactions between the various systems of a cell, including the interactions between DNA, RNA and protein biosynthesis as well as learning how these interactions are regulated.

BRAIN, Bayer Schering Pharma collaborate in production process optimisation of steroid compounds

BRAIN AG, an European leader in white biotechnology and the global top 10 pharmaceutical corporation Bayer Schering Pharma AG co-operate in the field of production process optimisation of steroid compounds. The goal of the collaboration is the energy-efficient and thus sustainable fermentative production of steroid compounds using optimised microbial production strains taking plant derived raw materials as starting material.

2 Feb 2010

Argonaute binds to microRNA and shuts down protein production

Johns Hopkins scientists believe they may have figured out how genetic snippets called microRNAs are able to shut down the production of some proteins.

2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women’s Hospital, the H. Lee Moffitt Cancer Center, Dartmouth’s Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.

1 Feb 2010

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes in this second edition to Prof. Robert J. Lefkowitz (1943, New York, United States), investigator in the Department of Medicine at Duke University (United States).

29 Jan 2010

Econiche vaccine cited in February, 2010 issue of Scientific American

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that Econiche(TM), the world's first vaccine developed to reduce the shedding by cattle of Escherichia coli (E. coli) O157, has been cited in the February, 2010 issue of Scientific American (Vol. 302, # 2).

29 Jan 2010

New advances for detection of cancer featured as cover story in "Lab on a Chip" journal

New advances for the detection of cancer led by Rafael V. Davalos of the Virginia Tech-Wake Forest School of Biomedical Engineering and Science (SBES) are featured as the cover story in the January 19, 2010 Royal Society of Chemistry's magazine, "Lab on a Chip," the premier journal for researchers in microfluidics.

29 Jan 2010

GSA announces recipients of 2010 awards for distinguished service in the field of genetics

The Genetics Society of America (GSA) is pleased to announce the recipients of its five awards for distinguished service to the field of genetics. These awards represent sustained activity and contributions by members of the genetics community.

29 Jan 2010

Researchers reveal major shifts in structure of scientific research

How has the structure of scientific research changed over the past decade? A team of researchers from Ume- University, Sweden, and the University of Washington, USA, aims to answer this question and others in a study published on January 27th in the online, open-access journal PLoS ONE.

29 Jan 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Greg Morgan awarded the Derek Price/Rod Webster Prize

Greg Morgan, an Associate Professor of Philosophy at Stevens Institute of Technology, was recently awarded the Derek Price/Rod Webster Prize for best paper of 2009 in History of Science by the History of Science Society.

28 Jan 2010

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

In a study to be published this week, a research team is challenging a prevailing belief about the behavior of a human protein linked to the formation of cancer, possibly breathing new life into the search for therapies that will inhibit that protein from "turning on" genes involved in abnormal cell proliferation.

27 Jan 2010

Study sheds light on cellular communication systems involved in neurodegenerative, cancer and cardiovascular diseases

Cells rely on a range of signaling systems to communicate with each other and to control their own internal workings. Scientists from the European Molecular Biology Laboratory (EMBL) in Hamburg, Germany, have now found a way to hack into a vital communications system, raising the possibility of developing new drugs to tackle disorders like neurodegeneration, cancer and cardiovascular disease.

27 Jan 2010

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

27 Jan 2010

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.

27 Jan 2010

Applied Biosystems signs cross-licensing agreement with Idaho Technology

Applied Biosystems LLC, part of Life Technologies Corporation, and Idaho Technology, Inc. have signed a cross-licensing agreement which covers a broad range of products including hardware, software and reagents.

27 Jan 2010

Loss of key proteins may account for molecular abnormalities associated with myotonic dystrophy

Research on the genetic defect that causes myotonic muscular dystrophy has revealed that the mutation disrupts an array of metabolic pathways in muscle cells through its effects on two key proteins.

24 Jan 2010

Sexual reproduction leads to lesser accumulation of harmful DNA mutations than asexual reproduction

Living organisms have good reason for engaging in sexual, rather than asexual, reproduction according to Maurine Neiman, assistant professor of biology in the UI College of Liberal Arts and Sciences and researcher in the Roy J. Carver Center for Genomics.

22 Jan 2010

Thomas S. Kilduff named a Fellow of the AAAS

SRI International, an independent nonprofit research and development institute, announced today that Thomas S. Kilduff, Ph.D., director of SRI International's Center for Neuroscience, has been named a Fellow of the American Association for the Advancement of Science (AAAS).

22 Jan 2010

TriLink BioTechnologies and Nacalai USA enter into distribution agreement

TriLink BioTechnologies (TriLink), has entered into an agreement with Nacalai USA, Inc., a San Diego based manufacturing and marketing company, for the distribution of TriLink's modified nucleic acid products in Japan, Singapore, South Korea and Taiwan.

21 Jan 2010

Molecular Biology News and Research

Further Reading

BRAIN, Bayer Schering Pharma collaborate in production process optimisation of steroid compounds

Argonaute binds to microRNA and shuts down protein production

Thermo Fisher Scientific to acquire Finnzymes

Asuragen enters into research agreements to develop microRNA-based diagnostic test

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

Econiche vaccine cited in February, 2010 issue of Scientific American

New advances for detection of cancer featured as cover story in "Lab on a Chip" journal

GSA announces recipients of 2010 awards for distinguished service in the field of genetics

Researchers reveal major shifts in structure of scientific research

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Greg Morgan awarded the Derek Price/Rod Webster Prize

Researchers challenge prevailing belief about role of protein in abnormal cell proliferation

Study sheds light on cellular communication systems involved in neurodegenerative, cancer and cardiovascular diseases

FDA approves Novo Nordisk's Victoza for type 2 diabetes

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Applied Biosystems signs cross-licensing agreement with Idaho Technology

Loss of key proteins may account for molecular abnormalities associated with myotonic dystrophy

Sexual reproduction leads to lesser accumulation of harmful DNA mutations than asexual reproduction

Thomas S. Kilduff named a Fellow of the AAAS

TriLink BioTechnologies and Nacalai USA enter into distribution agreement

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News